Phase 2 Respiratory Clinical Trials
54 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 54 trials
Recruiting
Phase 2
Evaluation of the Clinical Efficacy of Antrrix Probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children
Recurrent Respiratory Tract Infections
Min-Tze LIONG120 enrolled2 locationsNCT07297966
Recruiting
Phase 1Phase 2
Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia
Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection+2 more
M.D. Anderson Cancer Center70 enrolled1 locationNCT04565665
Recruiting
Phase 2
Transpulmonary Assessment for Individualized Lung Optimization in Obese Patients
Respiratory Failure
University of Alberta30 enrolled2 locationsNCT07359261
Recruiting
Phase 2
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
Respiratory Syncytial Virus Infections
Shionogi192 enrolled64 locationsNCT07214571
Recruiting
Phase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
Acute Respiratory Distress Syndrome (ARDS)ARDSAcute Respiratory Distress Syndrome+1 more
PPD Development, LP200 enrolled36 locationsNCT06701669
Recruiting
Phase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Acute Respiratory Distress Syndrome (ARDS)ARDSAcute Respiratory Distress Syndrome+1 more
PPD Development, LP600 enrolled36 locationsNCT06703073
Recruiting
Phase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
Acute Respiratory Distress Syndrome (ARDS)ARDSAcute Respiratory Distress Syndrome+1 more
PPD Development, LP200 enrolled36 locationsNCT06701656
Recruiting
Phase 2
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
Acute Respiratory Distress Syndrome (ARDS)ARDSAcute Respiratory Distress Syndrome+1 more
PPD Development, LP200 enrolled36 locationsNCT06701682
Recruiting
Phase 2
Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial
Acute Respiratory Distress Syndrome (ARDS)Ventilator Management
Children's Hospital of Philadelphia160 enrolled1 locationNCT07123961
Recruiting
Phase 2
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
Respiratory Syncytial Virus Infections
GlaxoSmithKline184 enrolled37 locationsNCT07092865
Recruiting
Phase 2
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Hematopoietic and Lymphatic System NeoplasmAutoimmune DiseaseRespiratory Syncytial Virus Infection
Fred Hutchinson Cancer Center60 enrolled3 locationsNCT06817889
Recruiting
Phase 2
Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.
PneumoniaRespiratory InfectionAcute Respiratory Distress Syndrome+3 more
Vasomune Therapeutics, Inc.120 enrolled5 locationsNCT05123755
Recruiting
Phase 1Phase 2
Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis
Acute Respiratory Distress Syndrome
PT. Prodia Stem Cell Indonesia15 enrolled1 locationNCT07439848
Recruiting
Phase 2
Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.
InfluenzaAcute Respiratory Viral Infection
Valenta Pharm JSC300 enrolled11 locationsNCT07420985
Recruiting
Phase 1Phase 2
A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
Changchun Tuohua Pharmaceutical Co., Ltd.36 enrolled1 locationNCT07413978
Recruiting
Phase 2
A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age
Viral Respiratory InfectionViral Respiratory Illnesses
ENA Respiratory Pty Ltd1,100 enrolled5 locationsNCT07222670
Recruiting
Phase 2
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
InfectionsAcute Respiratory Distress Syndrome
BioAegis Therapeutics Inc.600 enrolled76 locationsNCT05947955
Recruiting
Phase 2Phase 3
A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
Acute Respiratory Distress Syndrome (ARDS)Acute Lung Injury(ALI)Sepsis Related Acute Lung Injury/Acute Respiratory Distress Syndrome
Shanghai University of Traditional Chinese Medicine60 enrolled1 locationNCT07342205
Recruiting
Phase 2
Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study
Acute Hypoxemic Respiratory Failure
Lorenzo delSorbo60 enrolled1 locationNCT07334379
Recruiting
Phase 1Phase 2
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection
Cystic Fibrosis LungRespiratory Infections, Recurrent, Chronic
Respirion Pharmaceuticals Pty Ltd72 enrolled22 locationsNCT06016088